| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/07/2004 | EP1404852A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 04/07/2004 | EP1404849A2 Modification of plant genomes by inducible site-specific recombination of transgenes |
| 04/07/2004 | EP1404848A2 Gene expression in plastids based on replicating vectors |
| 04/07/2004 | EP1404845A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404827A2 Lipolytic enzyme genes |
| 04/07/2004 | EP1404818A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2004 | EP1404817A2 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 04/07/2004 | EP1404816A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 04/07/2004 | EP1404815A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 04/07/2004 | EP1404813A2 Methods of culturing animal cells and polypeptide production in animal cells |
| 04/07/2004 | EP1404812A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 04/07/2004 | EP1404811A2 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 04/07/2004 | EP1404810A1 Culture media for plants and plant cells, tissues and organs containing an organic nitrogen source and a phosphorous ester source |
| 04/07/2004 | EP1404809A2 Improved skin substitutes and uses thereof |
| 04/07/2004 | EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404374A1 Slc2as as modifiers of the p53 pathway and methods of use |
| 04/07/2004 | EP1404368A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1404364A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
| 04/07/2004 | EP1404358A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404354A2 Chemically-modified progenipoietin conjugates |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404279A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1404256A2 Microfabricated tissue as a substrate for pigment epithelium transplantation |
| 04/07/2004 | EP1404180A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 04/07/2004 | EP1286708B1 Method for producing a bio-artificial transplant |
| 04/07/2004 | EP1238060B1 Method for production of a skin graft and the graft produced thereby |
| 04/07/2004 | EP1124843B1 Low allergenic protein variants |
| 04/07/2004 | EP1123384B1 Use of compositions depleted of dendritic cells for improving allogeneic hematopoietic cell transplantation |
| 04/07/2004 | EP0817836B1 Cell line and process for replicating rabies viruses and their quantitative detection |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0587791B1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences |
| 04/07/2004 | CN2609931Y Magnetic cell separation apparatus |
| 04/07/2004 | CN1487997A Gene HD3A inducing flowering of plant and utilization thereof |
| 04/07/2004 | CN1487996A Transgenic transchromosomal rodents for making human antibodies |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487084A Rice root system phosphorus starvation induction specific expression promoter and its plant culture method |
| 04/07/2004 | CN1486745A Stem cell prepn for treating tissue ischemia disease and its prepn process |
| 04/06/2004 | US6717032 Transgenic mice containing DEZ orphan receptor gene disruptions |
| 04/06/2004 | US6717030 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 04/06/2004 | US6716967 Purified monoclonal antibody or binding portion thereof that specifically binds to a rupestris stem pitting associated virus coat protein or coat protein polypeptide |
| 04/06/2004 | US6716965 Adipocyte complement related protein zacrp13 |
| 04/06/2004 | US6716882 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 04/06/2004 | US6716822 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716812 Calcitonin promotes fertilizing ability in mammalian sperm and is useful for treatment of conditions of low fertility in humans and animals |
| 04/06/2004 | US6716629 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 04/06/2004 | US6716628 Chondrogenesis promoters and indolin-2-one derivatives |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716612 Modifying the branching degree of amylopectin synthesized in plants, |
| 04/06/2004 | US6716600 Persephin and related growth factors |
| 04/06/2004 | US6716585 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716425 Administering to mammal cells modified by in vitro treatment with cytokine and gamma irradiation at dosage to irreversible arrest proliferation but not interfere with cytotoxicity |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2085232C Xylanase production |
| 04/06/2004 | CA2010321C Lymphocyte-associated cell surface protein |
| 04/03/2004 | CA2442521A1 Repressor-mediated selection strategies |
| 04/02/2004 | WO2004031372A1 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 04/02/2004 | CA2435274A1 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 04/01/2004 | WO2004027429A1 Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
| 04/01/2004 | WO2004027381A2 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 04/01/2004 | WO2004027073A1 Modified adenoviral vectors for use in vaccines and gene therapy |
| 04/01/2004 | WO2004027070A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | WO2004027067A2 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | WO2004027063A1 Use of sirnas for gene silencing in antigen presenting cells |
| 04/01/2004 | WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis |
| 04/01/2004 | WO2004027052A1 Th1 cell adoptive immunotherapy |
| 04/01/2004 | WO2004027051A2 Use of a fusion polypeptide for obtaining pluripotent nonembryonic stem cells |
| 04/01/2004 | WO2004027050A1 Method of immobilization of clusters of ligands on polymer surface and use n cell engineering |
| 04/01/2004 | WO2004027048A2 High titer recombinant aav production |
| 04/01/2004 | WO2004027043A2 Method for production of a multimeric protein by cell fusion |
| 04/01/2004 | WO2004027040A2 Devices and methods for isolating and recovering target cells |
| 04/01/2004 | WO2004027029A2 Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells |
| 04/01/2004 | WO2004027021A2 Device and methods for isolating target cells |
| 04/01/2004 | WO2004027014A1 Cell dispersing apparatus, cell dispersion cassette and tissue retention part |
| 04/01/2004 | WO2004026897A1 Wt1 substitution peptides |
| 04/01/2004 | WO2004026332A1 Methods of increasing platelet and hematopoietic stem cell production |
| 04/01/2004 | WO2004026254A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | WO2004026250A2 Re-activated t-cells for adoptive immunotherapy |
| 04/01/2004 | WO2004026227A2 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 04/01/2004 | WO2004026115A2 Theree-dimensional construct for the design and fabrication of physiological fluidic networks |
| 04/01/2004 | WO2004026026A1 7f4 gene transgenic animal |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004016766A3 Real time measurement of cellular responses |
| 04/01/2004 | WO2004016759A3 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/01/2004 | WO2004015056A3 Immunomodulating compositions, processes for their production and uses therefor |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007723A3 Genes |
| 04/01/2004 | WO2004005473A3 Hcv fusion proteins with modified ns3 domains |
| 04/01/2004 | WO2004005460A3 Antisense modulation of hmg-coa reductase expression |
| 04/01/2004 | WO2004001032A3 Stable adenoviral vectors and methods for propagation thereof |
| 04/01/2004 | WO2003106495A3 Humanized monoclonal antiboby hpam4 |
| 04/01/2004 | WO2003104443A3 Hair follicle mesenchymal stem cells and use thereof |
| 04/01/2004 | WO2003104402A3 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 04/01/2004 | WO2003103613A3 Induction of insulin expression |
| 04/01/2004 | WO2003102162A3 Novel tolerogenic dendritic cells and therapeutic uses therefor |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |